Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

The document concludes that various treatments, including laser therapy, are effective for managing pseudofolliculitis barbae, especially in darker skin types.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

Finasteride works better for hair loss in patients 26 or younger.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Cimetidine did not reduce hair growth in women with hirsutism.

Vitamin B12 deficiency can cause skin darkening and increased blood vessels, but treatment can improve symptoms.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Dutasteride effectively and safely treats male hair loss for over a year.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

BeauTop improves hair growth in androgenetic alopecia patients.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

A young woman's rare ovarian tumor was successfully removed, improving her hormonal symptoms.

Using platelet-rich plasma and fat grafting to treat nerve pain showed promising results with no side effects.